Ask AI
ProCE Banner Activity

The Future of HIV Prevention in Latin America

Conference Coverage
Clinical Thought

The future of HIV care in Latin America depends on aligning innovation with strong public health systems: As long-acting agents expand prevention options, their real-world impact will rely on the ability of health systems to deliver them equitably and safely. Recent data presented at CROI 2026 offer timely and practice-relevant insights for Latin America.

Released: March 09, 2026

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Disclosure

Primary Author

Emilia M. Jalil, MD, PhD: advisor/researcher: MSD